Does Gilead Sciences, Inc (NASDAQ:GILD) have deteriorating prospects?

Gilead Sciences, Inc (NASDAQ:GILD) shares traded 1.85% higher at $95.59 on Wall Street last session.

GILD stock price is now 4.07% away from the 50-day moving average and 20.41% away from the 200-day moving average. The market capitalization of the company currently stands at $119.13B.

With the price target enhanced from $87 to $113, Morgan Stanley Upgraded its rating from Equal-Weight to Overweight for Gilead Sciences, Inc (NASDAQ: GILD). , while ‘Wolfe Research’ rates the stock as ‘Outperform’

In other news, Dickinson Andrew D, Chief Financial Officer sold 2,500 shares of the company’s stock on Jan 15 ’25. The stock was sold for $228,375 at an average price of $91.35. Upon completion of the transaction, the Chief Financial Officer now directly owns 129,873 shares in the company, valued at $12.41 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 15 ’25, Officer ANDREW DICKINSON bought 2,500 shares of the business’s stock. A total of $228,375 was incurred on buying the stock at an average price of $91.35. A total of 0.10% of the company’s stock is owned by insiders.

During the past 12 months, Gilead Sciences, Inc has had a low of $62.07 and a high of $98.90. As of last week, the company has a debt-to-equity ratio of 1.26, a current ratio of 1.26, and a quick ratio of 1.10. According to the stock market information, the enterprise value for the company is $133430050816, which is based on a 1077.68 price-to-earnings ratio, a 187.42 price-to-earnings-growth ratio, and a beta of 0.20. The fifty day moving average price for GILD is $91.8502 and a two-hundred day moving average price translates $79.3843 for the stock.

The latest earnings results from Gilead Sciences, Inc (NASDAQ: GILD) was released for 2024-09-30. The net profit margin was 0.45% and return on equity was 0.62% for GILD. The company reported revenue of $7.54 billion for the quarter, compared to $7.05 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 7.01 percent.

Related Posts

Fosters Research
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.